Bastide Le Confort Médical SA (EPA:BLC)

EPA:BLC Financials Overview

Financials in millions EUR. Fiscal year is July - June.

Revenue & Profits

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Revenue Revenue Growth	510.46	491.18	461.87	508.03	468.3	444.07
Revenue Growth	3.93%	6.35%	-9.09%	8.48%	5.46%	16.04%
Gross Profit Gross Profit Growth	344	333	308.63	333.73	306.8	280.26
Operating Income Operating Income Growth	47.77	45.19	38.52	42.82	38.93	37.5
Net Income Net Income Growth	29.47	0.53	-0.9	12.05	13.68	13.45
Earnings Per Share EPS Growth	3.61	0.07	-0.11	1.52	1.86	1.83
EPS Growth	5053.36%	-	-	-18.28%	1.64%	15.90%

Revenue by Segment

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Respiratory Support Respiratory Support Growth	129.21	123.89	108.12	92.57	80.83	113.8
Nutrition Infusion Nutrition Infusion Growth	86.41	85.79	81.45	73.94	58.96	100.28
Diabetes Diabetes Growth	30.83	27.26	21.97	17.51	14.33	-
Stomatherapy-Urology-Healing Stomatherapy-Urology-Healing Growth	27.1	26.15	25.33	38	45.63	-
Home Support Home Support Growth	197.21	191.79	190.56	195.52	193.32	230
Others Others Growth	-	-	0.05	0.06	-	-
Unallocated Foreign Subsidiaries Unallocated Foreign Subsidiaries Growth	39.51	36.3	34.39	90.43	75.24	-
Total Total Growth	510.46	491.18	461.87	508.03	468.3	444.07

Cash & Debt

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Cash & Investments Cash & Investments Growth	25.47	25.49	23.62	36.71	22.13	33.74
Total Debt Total Debt Growth	324.13	411.16	408.65	427.39	419.23	357.62
Net Cash (Debt) Net Cash Growth	-298.66	-385.67	-385.03	-390.69	-397.1	-323.88
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share Net Cash Per Share Growth	-36.53	-48.59	-48.49	-49.22	-53.86	-44.02

Cash Flow & CapEx

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Operating Cash Flow Operating Cash Flow Growth	113.56	101.82	73.91	105.68	56.86	74.36
Capital Expenditures CapEx Growth	-58.1	-60.08	-49.45	-53.63	-53.27	-46.51
Free Cash Flow Free Cash Flow Growth	55.46	41.74	24.46	52.05	3.59	27.85
Free Cash Flow Growth	32.84%	70.68%	-53.01%	1351.37%	-87.12%	269.46%

Margins

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Gross Margin	67.39%	67.80%	66.82%	65.69%	65.51%	63.11%
Operating Margin	9.36%	9.20%	8.34%	8.43%	8.31%	8.45%
Pretax Margin	2.81%	2.15%	2.84%	4.48%	4.49%	4.54%
Profit Margin	5.77%	0.11%	-0.19%	2.37%	2.92%	3.03%
FCF Margin	10.86%	8.50%	5.29%	10.24%	0.77%	6.27%

Dividends

Chart

Fiscal Year	FY 2021
Period Ending	Jun 30, 2021
Dividend Per Share Dividend Per Share Growth	0.270
Dividend Per Share Growth	0%
Dividend Yield	0.57%

Valuation

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 23, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
PE Ratio	19.03	439.54	-	17.34	18.86	25.80
Forward PE	13.41	10.15	6.01	8.91	12.44	18.40
P/FCF Ratio	3.07	5.56	5.48	4.01	71.95	12.46
PS Ratio	0.33	0.47	0.29	0.41	0.55	0.78

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Aug 19, 2026

Data Sources Report a data error